#63 – I Never Metapneumovirus that Required Antibiotics: Prevention & Treatment of Common Respiratory Viruses in Adults

#63 – I Never Metapneumovirus that Required Antibiotics: Prevention & Treatment of Common Respiratory Viruses in Adults

Author: Society of Infectious Diseases Pharmacists September 16, 2022 Duration: 0:00
Breakpoints
HealthEducationScience

Episode Notes

Drs. Ann Falsey, Crystal Hodge (@Howzzeee) and Michael Ison (@MichaelGIsonMD) join Dr. Jillian Hayes (@thejillianhayes) for a review of non-COVID respiratory viruses. Tune in for a review of current epidemiological changes, the vaccine pipeline, and current treatment options. 

This episode was supported by an educational grant from Janssen Therapeutics, Division of Janssen Products, LP.

Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About Twitter: @SIDPharm (https://twitter.com/SIDPharm) Instagram: @SIDPharm (https://www.instagram.com/sidpharm/) Facebook: https://www.facebook.com/sidprx LinkedIn: https://www.linkedin.com/company/sidp

References

  1. Community-acquired respiratory viruses in transplant patients (PMID 31511250)
  2. Clinical Transplantation 2019 special issue on Transplant Infectious Diseases Guidelines: ](https://urldefense.com/v3/https:/onlinelibrary.wiley.com/toc/13990012/2019/33/9;!!OToaGQ!ujpO69U-82gjgidcyi6YshodQ4umKoYBRbC6wcHf-7QtOVoXotlCzZSwBl7eXjGal8O6D5qQIF8k7_GUOsi3weedNyWNXbw$)[https://onlinelibrary.wiley.com/toc/13990012/2019/33/9
  3. ECIL-4 Fourth European Conference on Infections in Leukaemia (ECIL-4): Guidelines for Diagnosis and Treatment of Human Respiratory Syncytial Virus, Parainfluenza Virus, Metapneumovirus, Rhinovirus, and Coronavirus https://doi.org/10.1093/cid/cis844
  4. JID RSV Supplements: https://academic.oup.com/jid/issue/226/Supplement_1, https://academic.oup.com/jid/issue/226/Supplement_2 
  5. CID Precision Vaccinology Supplement: https://academic.oup.com/cid/issue/75/Supplement_1 
  6. Net State of Immunosuppression (PMID 32803228)
  7. Inflammatory and Infectious Syndromes Associated With Cancer Immunotherapies (PMID 30520987)
  8. Biologic response modifiers (PMID 28263774)
  9. Invasive fungal infections and targeted therapies in hematologic malignancies (PMID 34947040)
  10. Impact of COVID-19 on Influenza vaccination strategies (PMID 35607766)
  11. Zanamivir vs oseltamivir (PMID 35299245)
  12. Peramivir vs oseltamivir (PMIDs 33447633, 33006445)
  13. FLAGSTONE (PMID 35085510)
  14. CAPSTONE-2 (PMID 32526195) 
  15. Neuraminidase inhibitor benefits beyond 48 hours (PMID 33434667, 32898685, 24815805, 24268590)
  16. Baloxavir for prophylaxis of household contacts (PMID 32640124)
  17. Oral ribavirin for RSV in HCT (PMID 30202920)
  18. Ribavirin for RSV and human metapneumovirus in HCT (PMID 32162389)
  19. DAS181 for parainfluenza virus (PMID 33569576)

Check out our podcast host, Pinecast. Start your own podcast for free with no credit card required. If you decide to upgrade, use coupon code r-7e7a98 for 40% off for 4 months, and support Breakpoints.


Hosted by the Society of Infectious Diseases Pharmacists, Breakpoints is a podcast dedicated to the intricate and ever-evolving world of antimicrobial therapy. Each episode delves into the practical challenges and scientific nuances faced by pharmacists on the front lines of patient care, from interpreting susceptibility data and optimizing dosing strategies to navigating the complexities of antimicrobial stewardship. The conversations in this podcast bridge the gap between groundbreaking infectious diseases research and its direct application in clinical settings, offering insights that are both academically rigorous and immediately useful. You’ll hear expert discussions on new resistance patterns, evolving treatment guidelines, and the real-world implementation of life-saving protocols. Designed for healthcare professionals committed to precision medicine, Breakpoints provides a deeper understanding of how to effectively manage infections and improve patient outcomes. Tune in for thoughtful analysis and forward-thinking dialogue that defines the critical role of specialized pharmacists in public health.
Author: Language: en-us Episodes: 100

Official website RSS
instagramlinkedin
Breakpoints
Podcast Episodes
#134 – ESCMID Global Trials: PETER PEN and ASTARTE [not-audio_url] [/not-audio_url]

Duration: 1:03:15
Professor Mical Paul and Professor Jesús Rodríguez-Baño join Professor Josh Davis and Dr Erin McCreary for a special Breakpoints and Communicable podcast collaboration. This episode discusses the ‘Trials Run’ session at…
#130 – Dosing Consult: Amoxicillin [not-audio_url] [/not-audio_url]

Duration: 1:00:17
Drs. Ted Morton and Christine Lockowitz join Dr. Ryan Moenster to discuss all things amoxicillin, particularly in our pediatric patients. Our guests answer common questions, such as, what formulations should be used for…
#129 – Game of Spores: Blasto, Histo, Crypto, and Cocci [not-audio_url] [/not-audio_url]

Duration: 1:22:58
We’re starting 2026 off with a BLAST as Dr. Gregory Eschenauer and Dr. George R Thompson make their Breakpoints debut to discuss Blastomyces, Histoplasma, Coccidioides, and Cryptococcus. They join host Erin McCreary in r…
#128 – IDWeek 2025 Recap [not-audio_url] [/not-audio_url]

Duration: 1:35:54
Ring in the end of the year with our Breakpoints hosts and a review of all things IDWeek 2025! Join Drs. Erin McCreary, Julie Ann Justo, Whitney Buckel, and Ryan Moenster as they cover top late breaking abstracts, new st…
#127 – What’s Pneu in Community-Acquired Pneumonia Part 2 [not-audio_url] [/not-audio_url]

Duration: 52:27
As promised, our host Dr, Ryan Moenster is back and breaking down the recently published ATS pneumonia guidelines — what’s pneu, what’s controversial, and what it means for your antimicrobial game! Dr. Whitney Hartlage (…
#126 – What’s the Microbiome Gut to Do with It [not-audio_url] [/not-audio_url]

Duration: 1:08:15
Dr. Julie Ann Justo is joined by experts Drs. Krista Gens and Javier A. Villafuerte Gálvez as they dive deep into the gut microbiome and explore the latest therapeutic frontier for C. difficile infections. From bacteria…

12345...10»